Chugai Pharmaceutical

Chugai Pharmaceutical

World Rank (Jan-05-2024)
272
Market Cap (Jan-05-2024)
61.045 Billion USD
World Rank (Jul-30-2023)
363
Market Cap (Jul-30-2023)
48.058 Billion USD
World Rank (Jan-07-2022)
355
Market Cap (Jan-07-2022)
52.995 Billion USD
World Rank (Jan-01-2021)
160
Market Cap (Jan-01-2021)
86.930 Billion USD
Company Rank in Country in 2023
Rank in Japan in 2023 is 25
Headquarters Country
Japan
Market Cap (Mar-08-2026)
99.95
CEO
Tatsuro Kosaka
Chairman
Christoph Franz
Founders
Juzo Ueno
Employee Count
7,771
Employee Count as of Date
As on 2022
Headquarters City/State
Tokyo
World Region
Asia
World Subregion
Eastern Asia
Annual Revenue in USD
8,925 Million USD
Annual Operating Income in USD
3,778 Million USD
Annual Net Income in USD
2,652 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
13,245 Million USD
Total Liabilities in USD
3,155 Million USD
Total Equity in USD
10,090 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Company Website
CHUGAI PHARMACEUTICAL CO.,LTD.
Wikipedia
Wikipedia
Yahoo
Yahoo @ Tokyo
Company Profile

CHUGAI PHARMACEUTICAL is Pharmaceutical company with headquarters is in Japan.

Annual Results Summary

CHUGAI PHARMACEUTICAL- Annual Results Summary - in Billion JPY:

Year EndingRevenueGross ProfitOperating incomeNet income
Dec-20221,259.9783.6533.3374.4
Dec-2021999.7661.6421.8302.9
Dec-2020786.9511.8306.9214.7
Dec-2019686.2419.9214.5157.6
Dec-2018579.8316.0129.292.5
Dec-2017534.2279.6103.072.7
Dec-2016491.8243.679.353.6
Balance Sheet Summary

CHUGAI PHARMACEUTICAL - Balance Sheet Summary - in Billion JPY:

Year EndingTotal AssetsTotal liabilitiesTotal equity
Dec-20221,8694451,424
Dec-20211,5383501,188
Dec-20201,235255980
Dec-20191,059205854
Dec-2018920163756
Dec-2017852160692
Dec-2016806160646
Founded Year
1943
Stock Category
NIKKEI 225
Stock Exchange
Tokyo

Share